Cargando…

Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients

BACKGROUND AND AIMS: Interferon beta (IFNb) is a safe first-line drug commonly used for relapsing-remitting (RR)-MS. Nevertheless, a considerable proportion of patients do not respond to IFNb treatment. Therefore, until now, a number of studies have investigated various markers that could predict th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stampanoni Bassi, Mario, Drulovic, Jelena, Pekmezovic, Tatjana, Iezzi, Ennio, Sica, Francesco, Gilio, Luana, Gentile, Antonietta, Musella, Alessandra, Mandolesi, Georgia, Furlan, Roberto, Finardi, Annamaria, Marfia, Girolama Alessandra, Bellantonio, Paolo, Fantozzi, Roberta, Centonze, Diego, Buttari, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727083/ https://www.ncbi.nlm.nih.gov/pubmed/33343708 http://dx.doi.org/10.1177/1756286420970833

Ejemplares similares

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2021)

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
por: Gilio, Luana, et al.
Publicado: (2022)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
por: Azzolini, Federica, et al.
Publicado: (2022)

Synaptic Plasticity Shapes Brain Connectivity: Implications for Network Topology
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2022)

Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2022)

A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
por: De Vito, Francesca, et al.
Publicado: (2021)

The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
por: Mandolesi, Georgia, et al.
Publicado: (2021)

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
por: Albanese, Maria, et al.
Publicado: (2016)

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
por: Musella, Alessandra, et al.
Publicado: (2018)

Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
por: Rizzo, Francesca Romana, et al.
Publicado: (2018)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2019)

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2015)

Case Report: Overlap Between Long COVID and Functional Neurological Disorders
por: Gilio, Luana, et al.
Publicado: (2022)

COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
por: Buttari, Fabio, et al.
Publicado: (2021)

Re-Examining the Role of TNF in MS Pathogenesis and Therapy
por: Fresegna, Diego, et al.
Publicado: (2020)

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2020)

Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2020)

Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2021)

Cannabinoids in Parkinson's Disease
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
por: Musella, Alessandra, et al.
Publicado: (2020)

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2016)

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
por: Rossi, Silvia, et al.
Publicado: (2014)

Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis
por: Gentile, Antonietta, et al.
Publicado: (2016)

Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
por: Gentile, Antonietta, et al.
Publicado: (2018)

Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy
por: Parisi, Vincenzo, et al.
Publicado: (2023)

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
por: Landi, Doriana, et al.
Publicado: (2022)

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023)

Fingolimod Immune Effects Beyond Its Sequestration Ability
por: Sica, Francesco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8cr941okvhajqt38fi08i5be17